Jiang X - Search Results

1

Efficacy and safety of PD-1 blockade-activated neoantigen specific cellular therapy for advanced relapsed non-small cell lung cancer.

Qiao Y, Hui K, Hu C, Wang M, Sun W, Liu L, Dong C, Jiang X. Qiao Y, et al. Among authors: jiang x. Cancer Immunol Immunother. 2025 Jan 3;74(2):60. doi: 10.1007/s00262-024-03906-z. Cancer Immunol Immunother. 2025. PMID: 39751937 Free PMC article. Clinical Trial.

2

Carrelizumab combined with anlotinib in the treatment of extensive-stage small cell lung cancer: A case report.

Liu L, Zhang X, Zhou L, Yang T, Qiao Y, Jiang X. Liu L, et al. Among authors: jiang x. Medicine (Baltimore). 2021 Sep 3;100(35):e27138. doi: 10.1097/MD.0000000000027138. Medicine (Baltimore). 2021. PMID: 34477165 Free PMC article.

3

The role of plasma exosomal lnc-SNAPC5-3:4 in monitoring the efficacy of anlotinib in the treatment of advanced non-small cell lung cancer.

Liu C, Hu C, Chen T, Jiang Y, Zhang X, Liu H, Wang Y, Li Z, Hui K, Jiang X. Liu C, et al. Among authors: jiang x, jiang y. J Cancer Res Clin Oncol. 2022 Oct;148(10):2867-2879. doi: 10.1007/s00432-022-04071-5. Epub 2022 Jun 7. J Cancer Res Clin Oncol. 2022. PMID: 35672525 Clinical Trial.

4

Plasma sPD-L1 and VEGF levels are associated with the prognosis of NSCLC patients treated with combination immunotherapy.

Dong C, Hui K, Gu J, Wang M, Hu C, Jiang X. Dong C, et al. Among authors: jiang x. Anticancer Drugs. 2024 Jun 1;35(5):418-425. doi: 10.1097/CAD.0000000000001576. Epub 2024 Feb 23. Anticancer Drugs. 2024. PMID: 38386011

5

Case report: Combination therapy of envafolimab with endostar for advanced non-small cell lung cancer with low PD-L1 expression.

Wu S, Dong C, Hu C, Hui K, Jiang X. Wu S, et al. Among authors: jiang x. Front Oncol. 2024 Nov 7;14:1437260. doi: 10.3389/fonc.2024.1437260. eCollection 2024. Front Oncol. 2024. PMID: 39575420 Free PMC article.

6

Clinical study on the recombinant human endostatin regarding improving the blood perfusion and hypoxia of non-small-cell lung cancer.

Jiang XD, Dai P, Qiao Y, Wu J, Song DA, Li SQ. Jiang XD, et al. Clin Transl Oncol. 2012 Jun;14(6):437-43. doi: 10.1007/s12094-012-0821-3. Clin Transl Oncol. 2012. PMID: 22634532 Clinical Trial.

7

Study on lung cancer cells expressing VEGFR2 and the impact on the effect of RHES combined with radiotherapy in the treatment of brain metastases.

Jiang XD, Ding MH, Qiao Y, Liu Y, Liu L. Jiang XD, et al. Clin Lung Cancer. 2014 Mar;15(2):e23-9. doi: 10.1016/j.cllc.2013.11.012. Epub 2013 Nov 20. Clin Lung Cancer. 2014. PMID: 24374073 Clinical Trial.

8

Updating advances on recombinant human endostatin combined with radiotherapy for non-small cell lung cancer with brain metastasis.

Jiang XD, Qiao Y. Jiang XD, et al. Transl Lung Cancer Res. 2012 Mar;1(1):84-8. doi: 10.3978/j.issn.2218-6751.2011.12.06. Transl Lung Cancer Res. 2012. PMID: 25806159 Free PMC article.

9

The effect of anti-angiogenic drugs on regulatory T cells in the tumor microenvironment.

Hu C, Jiang X. Hu C, et al. Among authors: jiang x. Biomed Pharmacother. 2017 Apr;88:134-137. doi: 10.1016/j.biopha.2017.01.051. Epub 2017 Jan 16. Biomed Pharmacother. 2017. PMID: 28103506 Review.

10

Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer.

Liang LJ, Hu CX, Wen YX, Geng XW, Chen T, Gu GQ, Wang L, Xia YY, Liu Y, Fei JY, Dong J, Zhao FH, Ahongjiang Y, Hui KY, Jiang XD. Liang LJ, et al. Cancer Res Treat. 2020 Apr;52(2):406-418. doi: 10.4143/crt.2019.296. Epub 2019 Sep 3. Cancer Res Treat. 2020. PMID: 31476848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,744 results

Search Page

Filters